The Biden administration’s Wednesday decision to support waiving intellectual-property protections for COVID-19 vaccines counts as a significant disappointment for drugmakers, who rank among the biggest spenders on Washington lobbying.
‘I have a $3,000-a-month pension. I am living with my ill father, and I am currently not working and looking for a job. I am going to college using the GI Bill. I am almost 50, and have no 401(k).’
Central bank news conferences are typically most interesting at their very beginning, when there is still uncertainty over what policy makers are trying to communicate, and at the very end, when reporters start asking less obvious questions.
Oil futures trade lower Thursday, extending the previous session’s decline, as investors weigh disappointing data on U.S. gasoline usage and keep an eye on surging COVID-19 infections in India.
The tech-heavy Nasdaq is set to outpace other stock market indexes at the open on Thursday, ready to recover from a more than 2% slide since the beginning of this week.